• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,763.91 261.79
( 0.34%)
Global Indices
Nasdaq
52,909.39 583.15
(1.11%)
Dow Jones
7,503.05 -1.18
(-0.02%)
Hang Seng
69,733.68 1,000.53
(1.46%)
Nikkei 225
10,673.34 20.47
(0.19%)
Forex
USD-INR
94.99 0.39
(0.42%)
EUR-INR
108.21 0.30
(0.28%)
GBP-INR
125.93 0.66
(0.53%)
JPY-INR
0.58 0.00
(0.27%)

EQUITY - MARKET SCREENER

Vivimed Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532660
INE526G01021
0.9167078
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VIVIMEDLAB
0
47.92
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

Indo Cotspin reports standalone net loss of Rs 0.03 crore in the March 2026 quarter
May 13,2026
Net Loss of Indo Cotspin reported to Rs 0.03 crore in the quarter ended March 2026 as against net loss of Rs 0.01 crore during the previous quarter ended March 2025. Sales declined 5.98% to Rs 5.97 crore in the quarter ended March 2026 as against Rs 6.35 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.01 crore in the year ended March 2026 as against net profit of Rs 0.40 crore during the previous year ended March 2025. Sales declined 1.32% to Rs 24.61 crore in the year ended March 2026 as against Rs 24.94 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales5.976.35 -6 24.6124.94 -1
OPM %2.012.52 -2.233.13 -
PBDT0.110.15 -27 0.501.12 -55
PBT-0.020.01 PL 0.010.56 -98
NP-0.03-0.01 -200 -0.010.40 PL